SVNT Financial Facts
Loss before income taxes: -26.69MProduct sales, net: 4.69M
See Full Income Statement
Accounts receivable, net: 3.82M
Total current assets: 80.5M
See Full Balance Sheet
Earnings History for Savient Pharmaceuticals, Inc. (SVNT)
|
Expand Research on SVNT
| Next EPS Date | 8/7/13 *Est. | EPS Growth Rate | +30.6% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +8.2% | Revenue Growth Rate | +34.3% *Last Qtr. |
| Average % Move 1-Wk after EPS | -4.8% |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Estimize EPS/Revs | Gd. | % Since | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
3/19/13  |
 |
Q412 | -$0.39 | -$0.44 | +$0.05 | $4.95M | $6.18M | N/A / N/A | N/A | 0% | Details |
| 11/8/12 |
|
Q312 | -$0.56 | -$0.48 | -$0.08 | $4.9M | $5.85M | N/A / N/A | N/A | -47.1% | Details |
| 5/15/13 | Q113 | -$0.34 | -$0.31 | -$0.03 | $4.7M | $5.65M | N/A / N/A | N/A | 0% | Details | |
| 8/8/12 |
Q212 | -$0.23 | -$0.44 | +$0.21 | $4.6M | $5.24M | N/A / N/A | N/A | 0% | Details | |
| 2/27/12 |
|
Q411 | -$0.44 | -$0.38 | -$0.06 | $3.71M | $3.51M | N/A / N/A | N/A | -65.1% | Details |
| 5/9/12 |
Q112 | -$0.49 | -$0.46 | -$0.03 | $3.5M | $4.59M | N/A / N/A | N/A | -59.3% | Details | |
| 11/3/11 |
|
Q311 | -$0.39 | -$0.40 | +$0.01 | $2.58M | $3.17M | N/A / N/A | N/A | -79.3% | Details |
| 8/4/11 |
|
Q211 | -$0.43 | -$0.30 | -$0.13 | $2M | $2.77M | N/A / N/A | N/A | -88.5% | Details |
